Effect of feed restriction on plasma dantrolene concentrations in horses

被引:8
作者
McKenzie, E. C. [1 ]
Garrett, R. L. [1 ]
Payton, M. E. [2 ]
Riehl, J. H. [1 ]
Firshman, A. M. [3 ]
Valberg, S. J. [3 ]
机构
[1] Oregon State Univ, Dept Clin Sci, Corvallis, OR 97331 USA
[2] Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA
[3] Univ Minnesota, Dept Vet Populat Med, Minneapolis, MN 55455 USA
关键词
horse; bioavailability; spectrofluorometry; equine; oral; CREATINE-KINASE ACTIVITY; RECURRENT EXERTIONAL RHABDOMYOLYSIS; MALIGNANT HYPERTHERMIA; MYOPLASMIC CALCIUM; SODIUM; EXERCISE; MANAGEMENT; MYOPATHY;
D O I
10.1111/j.2042-3306.2010.00262.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
P>Reasons for performing study: Dantrolene sodium is used to prevent exertional rhabdomyolysis in predisposed horses. Food intake might negatively impact dantrolene bioavailability in horses; however, prolonged feed restriction might be detrimental to performance. Objective: To determine a minimum duration of feed restriction that would optimise plasma dantrolene concentrations in horses after nasogastric administration. It was hypothesised that feed restriction for 4, 8 or 12 h before dantrolene administration would result in higher plasma dantrolene concentrations than achieved with no feed restriction before treatment. Methods: Five healthy horses were randomly rotated through 4 feed restriction periods of 0, 4, 8 and 12 h duration prior to nasogastric administration of dantrolene sodium (6 mg/kg bwt). Plasma dantrolene concentration was measured by spectrofluorometry at 60, 90, 120, 150, 180 and 210 min after administration. Data were analysed via repeated measures ANOVA. Results: Peak plasma dantrolene concentration was highest when horses had 0 and 4 h of feed restriction (0.65 +/- 0.10 mu g/ml at 120 min; 0.66 +/- 0.17 at 180 min, respectively) and was lower when horses were restricted from feed for 8 h (0.45 +/- 0.15 at 150 min) and 12 h (0.21 +/- 0.09 at 180 min). Mean plasma dantrolene concentration did not differ between 0 and 4 h feed restriction at any sample time, but feed restriction for 8 h resulted in significantly lower plasma dantrolene concentration at 60 and 180 min after treatment than when horses were restricted 0 and 4 h, respectively. Plasma dantrolene concentration was significantly lower at all sample times when horses were restricted from feed 12 h compared to 0 or 4 h. Conclusions: Absorption of nasogastrically administered dantrolene is inhibited by feed restriction before administration. To achieve optimal plasma dantrolene concentrations, feed restriction before oral administration should not exceed 4 h.
引用
收藏
页码:613 / 617
页数:5
相关论文
共 28 条
  • [1] PLASMA-LEVELS OF DANTROLENE FOLLOWING ORAL-ADMINISTRATION IN MALIGNANT HYPERTHERMIA-SUSCEPTIBLE PATIENTS
    ALLEN, GC
    CATTRAN, CB
    PETERSON, RG
    LALANDE, M
    [J]. ANESTHESIOLOGY, 1988, 69 (06) : 900 - 904
  • [2] DANTROLENE SODIUM AND HEPATIC-INJURY
    CHAN, CH
    [J]. NEUROLOGY, 1990, 40 (09) : 1427 - 1432
  • [3] PHARMACOKINETICS OF DANTROLENE SODIUM IN HORSES
    COURT, MH
    ENGELKING, LR
    DODMAN, NH
    ANWER, MS
    SEELER, DC
    CLARK, M
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1987, 10 (03) : 218 - 226
  • [4] Inheritance of recurrent exertional rhabdomyolysis in thoroughbreds
    Dranchak, PK
    Valberg, SJ
    Onan, GW
    Gallant, EM
    MacLeay, JM
    McKenzie, EC
    De La Corte, FD
    Ekenstedt, K
    Mickelson, JR
    [J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2005, 227 (05): : 762 - 767
  • [5] The efficacy of dantrolene sodium in controlling exertional rhabdomyolysis in the Thoroughbred racehorse
    Edwards, JGT
    Newton, JR
    Ramzan, PHL
    Pilsworth, RC
    Shepherd, MC
    [J]. EQUINE VETERINARY JOURNAL, 2003, 35 (07) : 707 - 711
  • [6] Epidemiologic characteristics and management of polysaccharide storage myopathy in Quarter Horses
    Firshman, AM
    Valberg, SJ
    Bender, JB
    Finno, CJ
    [J]. AMERICAN JOURNAL OF VETERINARY RESEARCH, 2003, 64 (10) : 1319 - 1327
  • [7] Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors
    Fruen, BR
    Mickelson, JR
    Louis, CF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (43) : 26965 - 26971
  • [8] Harris PA, 1997, CURRENT THERAPY EQUI, P115
  • [9] HODGSON DR, 1985, COMP CONT EDUC PRACT, V7, pS551
  • [10] INOTSUME N, 1986, PEDIATR PHARMACOL, V5, P253